Get Started

OVID

NASD Ovid Therapeutics Inc.
Oct 26, 2026 · 7:34 AM ET LAST TRADE Market Closed

$2.20 ↑ +0.04 (+1.85%) Trading Up from the previous close of $2.16

YTD change
+34.97%
vs 20-day SMA
-6.18%
vs 200-day SMA
-6.18%

Price ranges

Previous day
$2.12 $2.32
open $2.31 close $2.16
-$0.15 (-6.49%)
Today
$0.00 $0.00
$2.20
Past week
$2.12 $2.65
from $2.15 now $2.20
+$0.05 (+2.33%)
Past month
$2.09 $2.65
from $2.40 now $2.20
-$0.20 (-8.33%)
This year
$1.36 $3.11
from $1.63 now $2.20
+$0.57 (+34.97%)

Price & Performance

-0.53 (-19.70%) / 6M

$2.09$2.39$2.69$2.99Apr 27Jul 27Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 86.2% away from all-time highs of $15.93
  • OVID is up 35% since the beginning of the year
  • OVID is up 35% over the past 12 months
  • OVID is down 8% over the past 1 month
  • 10% of all OVID investors are betting against OVID

OVID reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +35.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.08
Earnings momentum +5.6% Quarterly EPS growth
Quarterly change +5.6%

Valuation

P/E ratio N/A
Enterprise value $322.0M
Beta 0.46

Balance sheet & scale

IncomeN/A
Revenue$1.6M
Cash$117.2M
Debt$12.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $429.7M

Ovid Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering better, gentler medicines for the brain. It discovers and develops differentiated, small molecule medicines for neurological and neuropsychiatric disorders with significant unmet need. The company was founded by Matthew During and Jeremy M. Levin on April 1, 2014 and is headquartered in New York, NY.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $439.26 -1.79%
MRNA Moderna, Inc. $200.10 -1.25%
RVMD Revolution Medicines, Inc. $186.99 -0.37%
ROIV Roivant Sciences Ltd. $36.49 -2.56%
BNTX BioNTech SE Sponsored ADR $88.12 -1.73%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.